Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Revista
País de afiliação
Intervalo de ano de publicação
1.
Stroke ; 41(5): 938-47, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20360544

RESUMO

BACKGROUND AND PURPOSE: Endovascular thrombectomy is an increasingly used treatment for arterial occlusion in acute stroke. Various devices (including most extensively the Mechanical Embolus Removal in Cerebral Ischemia [MERCI] Retriever device) have been used for this. METHODS: We review the neuropathologic findings in 5 patients (age range, 59 to 87 years) who died acutely or as late as 38 days after procedures using the MERCI (4 patients) and Penumbra (1 patient) devices were carried out to remove thromboemboli from the middle cerebral artery. Partial recanalization was achieved by thrombectomy in all 5 patients. RESULTS: All patients showed extensive cerebral infarcts, 3 of 5 with clinical hemorrhagic transformations of the infarct or frank intraparenchymal hemorrhage after thrombectomy; in 1 case, this was judged to be at least partly on the basis of concomitant hypertensive microvascular disease. With 1 exception, basal arteries examined in detail by immunohistochemistry showed prominent, although usually nonocclusive (and generally nonulcerated), atheromata, often with significant luminal stenosis. One patient showed a subintimal dissection with resultant occlusion of the middle cerebral artery. CONCLUSIONS: In this highly selected group of patients, the vascular pathological abnormalities affecting basal arteries were variable, but complicated atherosclerosis was a common finding. Extensive irreversible brain necrosis before therapeutic procedures may have contributed to deaths.


Assuntos
Isquemia Encefálica/patologia , Isquemia Encefálica/cirurgia , Acidente Vascular Cerebral/patologia , Acidente Vascular Cerebral/cirurgia , Trombectomia , Idoso , Idoso de 80 Anos ou mais , Isquemia Encefálica/tratamento farmacológico , Isquemia Encefálica/mortalidade , Feminino , Humanos , Trombose Intracraniana/tratamento farmacológico , Trombose Intracraniana/mortalidade , Trombose Intracraniana/patologia , Trombose Intracraniana/cirurgia , Masculino , Pessoa de Meia-Idade , Acidente Vascular Cerebral/tratamento farmacológico , Acidente Vascular Cerebral/mortalidade , Hemorragia Subaracnóidea/tratamento farmacológico , Hemorragia Subaracnóidea/mortalidade , Hemorragia Subaracnóidea/patologia , Hemorragia Subaracnóidea/cirurgia , Trombectomia/mortalidade , Ativador de Plasminogênio Tecidual/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa